Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
														Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





TETRAHYDROFURAN								Related Pages
										*OSHA comments from the January 19, 1989 Final Rule on Air Contaminants Project extracted from 54FR2332 et. seq. This rule was remanded by the U.S. Circuit Court of Appeals and the limits are not currently in force.*
**CAS:** 109-99-9; **Chemical Formula:** (C2H4)2O
OSHA’s former PEL for tetrahydrofuran was 200 ppm as an 8-hour TWA. The Agency proposed revising this limit to 200 ppm TWA with a 15-minute STEL of 250 ppm and is establishing these limits, which are consistent with those recommended by the ACGIH, in the final rule. NIOSH (Ex. 8-47, Table N1) concurred with OSHA’s proposal to add a STEL for this substance. Tetrahydrofuran is a colorless liquid with an odor like that of ether.
This proposed limit was selected on the basis of extensive data from experimental animal studies. Lehmann and Flury (1943c/Ex. 1-879) reported irritation of the upper respiratory tract as well as kidney and liver injury in a number of animals exposed by inhalation to more than 3000 ppm tetrahydrofuran for 20 days, eight hours daily. Aqueous solutions exceeding a concentration of 20 percent tetrahydrofuran proved irritating to the skin of rabbits. One study (Stoughton and Robbins 1936/Ex. 1-597) found that tetrahydrofuran concentrations in excess of 25,000 ppm were needed to anesthetize dogs. The anesthesia process in these animals showed a delayed induction period and poor recovery. In other studies with dogs (Zapp 1971, as cited in ACGIH 1986/Ex. 1-3, p. 564), 200 ppm tetrahydrofuran in daily six-hour inhalation exposures produced an observable effect on the pulse pressure of these animals within three to four weeks; despite an exposure of nine weeks at this dosage level followed by three weeks at nearly twice this concentration, no histopathologic changes were observed in the critical organs. Studies (Jochmann 1961/Ex. 1-1021) in which tetrahydrofuran was given orally and peritoneally to a variety of laboratory animals resulted in both liver and kidney damage; however, some of the effects observed by this author may have been caused by peroxide contamination of the tetrahydrofuran. Oettel (as cited in ACGIH 1986/Ex. 1-3, p. 564) observed no kidney or liver damage in cats, rabbits, rats, or mice exposed repeatedly by inhalation to tetrahydrofuran at concentrations of 3400 to 17,000 ppm for as long as six hours. Technicians involved in the experiment of Stoughton and Robbins (1936/Ex. 1-597, described above) experienced severe headaches when conducting these experiments.
Dr. Larry Hecker, Director of Corporate Industrial Hygiene and Toxicology for Abbott Laboratories, commented that there was no toxicological basis to justify a STEL for tetrahydrofuran (Ex. 3-678). However, OSHA believes that the severe headaches experienced by researchers conducting animal experiments (Stoughton and Robbins 1936/Ex. 1-597) are indicative of an acute effect that constitutes material impairment of health and is best avoided by establishing a short-term limit. OSHA also notes that the ACGIH (Threshold Limit Values and Biological Exposure Indicies for 1988-1989, ACGIH 1988b) has not proposed to delete its recommended STEL for this substance. Therefore, OSHA finds that both a 200-ppm 8-hour TWA and a 250-ppm STEL are necessary to reduce the risk of long-term systemic and acute effects associated with exposure to tetrahydrofuran and is establishing these limits in the final rule.
										
							
								Page last reviewed:  September 28, 2011						Content source:  	National Institute for Occupational Safety and Health NIOSH
1988 OSHA PEL Project Documentation
Index of Chemical Names
Index of CAS Numbers Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue